Thursday, March 16, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Bio-Rad Contract Supports CDC Anthrax Assay Development

by Global Biodefense Staff
November 2, 2015

The Centers for Disease Control and Prevention this week announced intentions to award a sole source contract to AbD Serotec, a Bio-Rad company, to support anthrax diagnostics development.

The company will conduct Human Fab (Fragment Antigen Binding) generation and production against Anthrax Lethal Factor. The contract includes an option for either large-scale production of Fabs or conversion of optimal Fab pairs into full length human IgG1 monoclonal antibodies and performance of large scale production of full-length IgG1.

The materials will be used to increase sensitivity and specificity in a Lateral Flow Immunoassay for Lethal Factor and an Electrochemiluminescence (ECL) plate-based assay for anthrax toxins.

The acquisition is on behalf of the National Center for Immunization and Respiratory Diseases (NCIRD), Division of Bacterial Diseases’ Meningitis and Vaccine Preventable Diseases Branch (MVPDB), Microbial Pathogenesis and Immune Response (MPIR) Laboratory.

Tags: AnthraxAwardsBioterrorism

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC